AstraZeneca Long Term Debt 2010-2024 | AZN

AstraZeneca long term debt for the quarter ending September 30, 2024 was $28.887B, a 29.98% increase year-over-year.

  • AstraZeneca long term debt for 2023 was $22.365B, a 2.61% decline from 2022.
  • AstraZeneca long term debt for 2022 was $22.965B, a 18.37% decline from 2021.
  • AstraZeneca long term debt for 2021 was $28.134B, a 60.72% increase from 2020.

AstraZeneca Long Term Debt 2010-2024 | AZN

  • AstraZeneca long term debt for 2023 was $22.365B, a 2.61% decline from 2022.
  • AstraZeneca long term debt for 2022 was $22.965B, a 18.37% decline from 2021.
  • AstraZeneca long term debt for 2021 was $28.134B, a 60.72% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B